18655-52-2 Usage
General Description
3-(3-Methoxy-phenyl)-propylamine, also known as m-Methoxyphenylpropylamine or 3,4-Methylenedioxy-N-methylamphetamine, is a psychoactive drug and a derivative of amphetamine. It belongs to the group of substituted amphetamines, which are known for their stimulating and hallucinogenic effects. This chemical acts as a serotonin and norepinephrine reuptake inhibitor, leading to increased levels of these neurotransmitters in the brain. It is commonly used as a recreational drug due to its euphoric and empathogenic effects, but it is also being researched for potential therapeutic applications in the treatment of mood disorders and PTSD. However, it is important to note that the recreational use of 3-(3-Methoxy-phenyl)-propylamine is illegal in many countries due to its potential for abuse and addiction.
Check Digit Verification of cas no
The CAS Registry Mumber 18655-52-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,6,5 and 5 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 18655-52:
(7*1)+(6*8)+(5*6)+(4*5)+(3*5)+(2*5)+(1*2)=132
132 % 10 = 2
So 18655-52-2 is a valid CAS Registry Number.
InChI:InChI=1/C10H15NO/c1-12-10-6-2-4-9(8-10)5-3-7-11/h2,4,6,8H,3,5,7,11H2,1H3
18655-52-2Relevant articles and documents
A Route to the C,D,E Ring System of the Aspidosperma Alkaloids
Giampa, Geoffrey M.,Fang, Jian,Brewer, Matthias
, p. 3952 - 3955 (2016)
A short synthetic sequence leading to the formation of the C,D,E-ring subunit of the Aspidosperma alkaloids is reported. This route is based on a ring fragmentation/intramolecular azomethine ylide 1,3-dipolar cycloaddition reaction sequence that gives the
INTEGRIN ANTAGONIST CONJUGATES FOR TARGETED DELIVERY TO CELLS EXPRESSING LFA-1
-
Paragraph 0119; 0120, (2013/08/14)
The invention relates to compounds of formula I: wherein R1, R2, and n are defined in the detailed description and claims. In particular, the present invention relates to the compounds of formula I for use in the manufacture and delivery of conjugated moi
1,2,4-Triazine Derivatives, Preparation and Use Thereof in Human Therapy
-
Page/Page column 20-21, (2008/12/06)
The invention concerns 3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives of general formula (I), wherein: R1 and R2, identical or different, represent a branched or linear C1-C7 alkyl or alkenyl radical, a C1/s
